NVCT NUVECTIS PHARMA INC
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 9 analyst firms say about NUVECTIS PHARMA INC: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
6 rated views · 9 analyst/firm records · 9 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8069
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8053
Recent analyst activity · last 90 days
Our tracked history has 6 reports on NVCT from 6 analyst firms in the last 90 days (10 firms in the past year).
Comparing each firm's latest target with its previous one: 1 left it unchanged and 2 have their first observed target in the past year.
No firm's latest available rating differs from its previous one.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Cantor Fitzgerald | Pete Stavropoulos | Buy | 24 Aug 2026 | — |
| H.C. Wainwright | Joseph Pantginis | Buy | 24 Sep 2026 | 39.00 USD |
| Loop Capital | Elemer Piros | — | 1 Sep 2026 | 40.00 USD |
| Lucid Cap Mkts | Unnamed analyst | Buy | 1 Sep 2026 | — |
| Maxim Group | Naz Rahman | Buy | 1 Jun 2026 | 30.00 USD |
| Roth Capital | Jonathan Aschoff | Buy | 6 Jul 2026 | 33.00 USD |
| UBS | Unnamed analyst | — | 6 Jul 2026 | 33.00 USD |
| Weiss Ratings | Unnamed analyst | — | 21 Sep 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 07:02 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.